← Browse by Condition
Medical Condition

adhesive capsulitis

Total Trials
6
Recruiting Now
6
Trial Phases
Phase 4

ClinicalMetric tracks all active clinical trials for adhesive capsulitis sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.

Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.

Frequently Asked Questions — adhesive capsulitis Clinical Trials

How many clinical trials are currently recruiting for adhesive capsulitis?
ClinicalMetric currently tracks 6 actively recruiting clinical trials for adhesive capsulitis, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 6. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for adhesive capsulitis?
adhesive capsulitis research spans Phase 4 (1 trial). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a adhesive capsulitis clinical trial?
Eligibility criteria for adhesive capsulitis trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 4
1
Top Sponsors
Riphah International University 2 trials
Bahçeşehir University 1 trial
Foundation University Islamabad 1 trial
Massachusetts General Hospital 1 trial
Acibadem University 1 trial

Recruiting Clinical Trials

NCT07236229
Recruiting

The Effects of Immersive Virtual Reality in Patients With Grade 1-2 Adhesive Capsulitis

Enrollment
36 pts
Location
Turkey (Türkiye)
Sponsor
Bahçeşehir University
View Trial →
NCT06985836
Recruiting

Effect of Mulligan Mobilization With or Without Niel Asher Technique in Patients With Adhesive Capsulitis

Enrollment
42 pts
Location
Pakistan
Sponsor
Riphah International Universit...
View Trial →
NCT07576127
Recruiting

Effects of Gongs Mobilization and Proprioceptive Neuromuscular Facilitation in Patients With Adhesive Capsulitis

Enrollment
44 pts
Location
Pakistan
Sponsor
Riphah International Universit...
View Trial →
NCT06668415
Recruiting

Effects of Spencer Technique Following Hydrodilation in Patients With Adhesive Capsulitis

Enrollment
30 pts
Location
Pakistan
Sponsor
Foundation University Islamaba...
View Trial →
NCT02283996 Phase 4
Recruiting

Adhesive Capsulitis: Prospective Analysis of Efficacy and Financial Impact for Use of Physical Therapy in Treatment

Enrollment
260 pts
Location
United States
Sponsor
Massachusetts General Hospital
View Trial →
NCT07495306
Recruiting

Electrophysiologic Changes After Extended 360° Capsular Release

Enrollment
15 pts
Location
Turkey (Türkiye)
Sponsor
Acibadem University
View Trial →
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology